Cardinal Partners


	Alnylam Establishes New Research Program on Delivery of RNAi Therapeutics at MIT's Center for Cancer Research
	May 09, 2007
	Cubist Reports First Quarter 2007 Results
	April 18, 2007
	Alnylam Announces Advancement of a New RNAi Therapeutic Development Program for the Treatment of Liver Cancer
	April 17, 2007
	athenahealth Joins With the Iowa Medical Society; Offers On-Demand Clinical and Practice Management Services to Physicians
	April 10, 2007
	Bioconnect Systems Completes $8M Series A Financing
	April 05, 2007
	VISICU WINS TOP INNOVATOR OF THE YEAR AWARD
	April 03, 2007
	Saint Joseph's Opens First eICU(R) Facility in Southeast
	March 30, 2007
	Momenta Pharmaceuticals to Present At the Cowen and Company 27th Annual Health Care Conference
	March 08, 2007
	athenahealth to Present at 27th Annual Cowen and Company Healthcare Conference
	March 08, 2007
	INEX and Alnylam Announce Allowance of New U.S. Patent Covering Delivery of RNAi Therapeutics
	March 07, 2007
	Alnylam to Webcast at the Cowen and Company 27th Annual Health Care Conference
	March 07, 2007
	Sirtris Pharmaceuticals, Inc. Files for Initial Public Offering
	March 01, 2007
	Alnylam and Isis Announce Allowance of First U.S. Patent Covering Human microRNAs
	March 01, 2007
	Alnylam Scientist Awarded Two Industry Honors
	February 28, 2007
	Cubist Pharmaceuticals to Present at the Leerink Swann & Company Novel Antibiotic Conference
	February 28, 2007
	CodeRyte Named a Finalist in the 2007 SIIA Codie Awards
	January 31, 2007
	Alnylam and Inex Form Strategic Technology Alliance to Discover and Develop RNAi Therapeutics with Lipid-Based Delivery Formulations
	January 09, 2007
	Alnylam and Inex Form Strategic Technology Alliance to Discover and Develop RNAi Therapeutics with Lipid-Based Delivery Formulations
	January 09, 2007
	Cubist Pharmaceuticals Announces Fourth Quarter 2006 U.S. Net Product Revenues of $56.2 Million and Full Year 2006 U.S. Net Product Revenues of $189.5 Million
	January 08, 2007
	Alnylam Announces Key Product and Business Goals for 2007
	January 08, 2007
	Alnylam Announces Key Product and Business Goals for 2007
	January 08, 2007
	TWO OF COLORADO'S PREMIER CARDIOLOGY GROUPS SELECT ATHENAHEALTH'S WEB-BASED EMR AND REVENUE CYCLE MANAGEMENT SERVICES
	December 20, 2006
	ATHENAHEALTH AND AGILENCE HEALTH ADVISORS FORGE ALLIANCE; TARGET NEW YORK AND NEW JERSEY PHYSICIAN AND HOSPITAL MARKETS
	December 18, 2006
	Alnylam Announces Closing of Common Stock Offering
	December 15, 2006
	TRIANGLE ORTHOPAEDIC ASSOCIATES SELECTS ATHENAHEALTH'S WEB-BASED PRACTICE MANAGEMENT SERVICE
	December 14, 2006
	Alnylam Announces Proceeds of Common Stock Offering
	December 12, 2006
	Alnylam Announces Public Offering of 4,700,000 Shares of Common Stock
	December 11, 2006
	Alnylam Advances a Systemically Delivered RNAi Therapeutic Targeting PCSK9 for the Treatment of Hypercholesterolemia as New Development Program
	December 05, 2006
	Cubist Pharmaceuticals Licenses Rights for Development and Commercialization of CUBICIN in China to AstraZeneca
	December 04, 2006
	Sirtris Pharmaceuticals obtains exclusive rights to key sirtuin technology from MIT
	November 30, 2006
	Alnylam Initiates Clinical Program to Evaluate Anti-Viral Activity for ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection
	November 28, 2006
	Sirtris Pharmaceuticals: Resveratrol reduces fat and boosts endurance by activation of SIRT1, first aging gene shown to accelerate human metabolism
	November 16, 2006
	NORTHERN NEW ENGLAND METROPOLITAN MEDICAL RESPONSE SYSTEM AND ATHENAHEALTH PILOT NEW EMERGENCY RESPONSE MODEL
	November 15, 2006
	Isis and Alnylam Announce Issued U.S. Patent Broadly Covering Chemical Modifications of Oligonucleotide Therapeutics
	November 11, 2006
	Thomson acquires NexCura:Patient information and communications added to Healthcare Solutions
	November 07, 2006
	athenahealth Joins with the Arkansas Medical Society; Offers Clinical and Practice Management Services to Physicians
	November 07, 2006
	Alnylam and Yale University Scientists Demonstrate Therapeutic Silencing of Disease Target Associated with Acute Lung Injury Using RNAi
	November 06, 2006
	Momenta Pharmaceuticals Reports Financial Results for the Third Quarter of 2006
	November 03, 2006
	Alnylam Pharmaceuticals Reports Third Quarter 2006 Financial Results
	November 02, 2006
	Research published in Nature by Sirtris scientists is first demonstration in mammals that resveratrol, a sirtuin activator, can treat diseases of aging, such as diabetes. Sirtris Pharmaceuticals doses first diabetes patient in human clinical study.
	November 01, 2006
	Minnesota Hospital Outreach Lab Outsources Accounts Receivable Management to Per-Se Technologies
	October 31, 2006
	ATHENAHEALTH JOINS WITH WASHINGTON STATE MEDICAL ASSOCIATION TO HELP IMPROVE THE FINANCIAL AND CLINICAL PERFORMANCE OF THE STATE'S MEDICAL PRACTICES
	October 27, 2006
	Alnylam to Webcast Conference Call Discussing Third Quarter 2006 Financial Results
	October 26, 2006
	Sirtris Pharmaceuticals to Present at the C.E. Unterberg Towbin Life Sciences Conference, October 30th, 2006
	October 25, 2006
	ATHENAHEALTH FORMS STRATEGIC ALLIANCE WITH LONE STAR MSO TO HELP TEXAS PHYSICIANS BETTER MANAGE THEIR PRACTICES AND IMPROVE COLLECTIONS
	October 24, 2006
	Alnylam Announces Progress in Pre-Clinical Hypercholesterolemia RNAi Therapeutic and microRNA Programs
	October 23, 2006
	Cubist Pharmaceuticals Reports Third Quarter 2006 Results and First Profitable Quarter; GAAP Basic and Diluted Net Income $0.09 Per Share; Net Product Revenues $50.3 Million, up 66% vs. 3Q05
	October 18, 2006
	Alnylam Announces Progress in Pre-clinical Programs at the 36th Annual Society for Neuroscience Meeting
	October 16, 2006
	Alnylam Initiates Phase I Clinical Study of Inhaled Formulation of ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection
	October 11, 2006
	Alnylam Notified of Defense Appropriation Funding for Ongoing Development of RNAi Therapeutics
	October 04, 2006
	Sirtris Announces Clinical Results from Phase 1 Trials of SRT501, a Sirtuin Therapeutic, Company Initiates Phase 1b Study in Type 2 Diabetes Patients
	October 04, 2006
	Alnylam Awarded $23 Million U.S. Government Contract to Develop RNAi Therapeutics for Biological Threats
	September 28, 2006
	Sirtris Pharmaceuticals CEO to Speak at Technology Review's Emerging Technologies Conference at MIT on September 28th, 2006
	September 26, 2006
	US PATENT OFFICE RE-AFFIRMS VISICU’S eICU® PATENT
	September 26, 2006
	ATHENAHEALTH APPOINTS JAMES MACDONALD AS CHIEF OPERATING OFFICER
	September 25, 2006
	Biogen Idec and Alnylam Form Alliance to Discover and Develop Therapeutics for the Potential Treatment of Progressive Multifocal Leukoencephalopathy (PML); Collaboration to Focus on RNAi Therapeutics Targeting the JC Virus
	September 20, 2006
	ATHENAHEALTH NAMED AS ONE OF NEW ENGLAND'S FASTEST GROWING COMPANIES FOR THE SECOND STRAIGHT YEAR
	September 18, 2006
	Sirtris Pharmaceuticals Hires Mike Jirousek as SVP of Research
	September 12, 2006
	Sirtris Pharmaceuticals to Present at Think Equity Conference September 13th, 2006
	September 07, 2006
	Alnylam Awarded Federal Grant to Develop RNAi Therapeutics for Pandemic Flu
	September 06, 2006
	MOSES CONE HEALTH SYSTEM CONTINUES TRADITION OF PATIENT CENTRIC CARE WITH eICU® PROGRAM
	July 27, 2006
	VISICU Reports Second Quarter Results
	July 27, 2006
	Alnylam Pharmaceuticals Reports Second Quarter 2006 Financial Results; Increasing Revenue Drives Improvement in Year-over-Year Financials
	July 26, 2006
	Cleveland Clinic Physicians Use Advanced Visualization Technology
	July 25, 2006
	athenahealth introduces Healthcare industry's first economically sustainable, Service-based EMR offering for Medical Practices
	July 25, 2006
	Momenta Pharmaceuticals and Sandoz Sign Exclusive Collaboration to Develop Complex Generics and Follow-On Versions of Biotechnology Drugs
	July 25, 2006
	Sirtris Pharmaceuticals to Present at 5th InternationalMetabolic Diseases Drug Discovery World Summit
	July 20, 2006
	Cubist Pharmaceuticals Reports Second Quarter 2006 Results; Total Revenues $47.8 Million; Net Product Revenues $45.7 Million, up 78% Vs. 2Q05; GAAP Loss $0.09 Per Share; Non-GAAP Income $0.06 Per Share
	July 19, 2006
	Alnylam Receives New Issued U.S. Patent Broadly Covering Small Interfering RNAs and Strengthens Leadership in Intellectual Property for RNAi Therapeutics
	July 18, 2006
	Alnylam Announces Collaboration with University of Texas Southwestern Medical Center to Discover RNAi Therapeutics for Hypercholesterolemia; Collaboration to Focus on PCSK9, a Key Gene Involved in Metabolism of LDL-Cholesterol
	July 17, 2006
	Eclipsys Partners with athenahealthSM to Deliver Unique Ambulatory Care Solution
	July 17, 2006
	Alnylam and INEX Accelerate Collaboration on Systemic Delivery of RNAi Therapeutics; Positive Results for Systemic RNAi Support Advancement to Next Phase of Collaboration
	July 17, 2006
	Remote ICU Saves Lives in Intensive Care
	July 10, 2006
	ATHENAHEALTH RETAINS TOP RANKING IN THREE AMBULATORY BILLING AND SCHEDULING CATEGORIES ACCORDING TO KLAS 2006 MID-YEAR REPORT CARD
	June 29, 2006
	ATHENAHEALTH ON PACE TO SAVE OHIO PHYSICIANS OVER $80 MILLION IN AVERTED CLAIM DENIALS FROM HEALTH INSURERS
	June 23, 2006
	Rib-X Pharmaceuticals Raises $50 Million in Series C Financing
	June 20, 2006
	ATHENAHEALTH PARTNERS WITH NEW HAMPSHIRE MEDICAL SOCIETY TO HELP IMPROVE THE FINANCIAL AND CLINICAL PERFORMANCE OF THE STATE'S MEDICAL PRACTICES
	June 14, 2006
	ATHENAHEALTH APPOINTS RICHARD N. FOSTER TO BOARD OF DIRECTORS
	June 07, 2006
	Sirtris Announces First Phase 1 Trial of a Sirtuin Therapeutic
	June 07, 2006
	ATHENAHEALTH'S NEW WEB-BASED EMR SERVICE TO INCLUDE DIRECT ELECTRONIC CONNECTIVITY WITH LOCAL PHARMACIES
	May 30, 2006
	VISICU’S eICU® PROGRAM COMING TO ST. JOSEPH HEALTH SYSTEM
	May 16, 2006
	SISTERS OF MERCY HEALTH SYSTEM
	May 02, 2006
	Sirtris Pharmaceuticals Secures $37 Million in Financing
	April 20, 2006
	Sirtris Pharmaceuticals to present at BioCentury Future Leaders in the Biotech Industry Conference 2006
	April 15, 2006
	Alnylam Announces Appointment of John Maraganore, Ph.D., to Biotechnology Industry Organization's Board of Directors
	April 13, 2006
	Alnylam To Collaborate with United States Army on RNAi Therapeutics for Biodefense Threats
	April 12, 2006
	U.S. PATENT OFFICE ISSUES NOTICE OF INTENT TO ALLOW ALL 26 AMENDED CLAIMS OF VISICU’S eICU® PATENT AFTER REEXAMINATION
	April 11, 2006
	Sirtris Pharmaceuticals to present at SG Cowen 26th Annual Health Care Conference
	March 31, 2006
	Scientists 'silence gene' to slash cholesterol levels
	March 27, 2006
	Sirtris Pharmaceuticals’ Science of Sirtuins Highlighted by Scientific American
	February 13, 2006
	ATHENAHEALTH POSTS RECORD GROWTH IN 2005
	February 07, 2006
	RMS Partners With IntelliCare to Implement “KEY to Better Health”, A Renal Disease Management Program Focused on Chronic Kidney Disease (CKD)
	January 24, 2006
	Alnylam Announces Allowance of Additional U.S. Patent Broadly Covering RNAi Therapeutics
	January 24, 2006
	Alnylam Announces Public Offering of Common Stock
	January 23, 2006
	Remote ICU care keeps an eye out
	January 18, 2006
	Alnylam Announces Allowance of U.S. Patent Broadly Covering RNAi Therapeutics
	January 17, 2006
	Alnylam Initiates Second Phase I Clinical Study of ALN-RSV01
	December 19, 2005
	Alnylam Announces Pandemic Flu as Next Development Program
	December 14, 2005
	Treasures in the Trash
	December 12, 2005
	Sirtris Pharmaceuticals Hires Peter Elliott as SVP, Head of Development
	November 30, 2005
	Cubist Pharmaceuticals to Present at Lazard Capital Markets Life Sciences Conference
	November 23, 2005
	Cubist Pharmaceuticals Expands U.S. Hospital Sales Organization
	November 22, 2005
	Alnylam Added to NASDAQ Biotechnology Index
	November 21, 2005
	FDA Accepts CUBICIN(R) sNDA and Grants Priority Review
	November 17, 2005
	Alnylam Announces Progress in Pre-clinical Programs at the 35th Annual Society for Neuroscience Meeting; Pre-clinical Data from Parkinson's Disease, Huntington's Disease, and Neuropathic Pain Programs
	November 15, 2005

Current Portfolio News

Archive Portfolio News